The DLEU2, DLEU1, MIRN15A, and MIRN16-1 genes within this cluster, either independently or jointly, play important roles in the pathogenesis, disease progression, and response to treatment regimens in CLL. This evidence concerns the gene DLEU2 and B-cell chronic lymphocytic leukemia.